GERN
Closed
Geron Corporation
1.38
-0.03 (-2.13%)
Last Update: 01 Jul 2025 23:15:00
Yesterday: 1.41
Day's Range: 1.37 - 1.47
Send
sign up or login to leave a comment!
When Written:
2.165
Geron Corporation is a biopharmaceutical company that specializes in the development of therapies for cancer and chronic degenerative diseases. The company was founded in 1990 and is headquartered in Menlo Park, California.
Geron's lead drug candidate is imetelstat, which is being developed as a treatment for myelofibrosis, a type of blood cancer, and for solid tumors such as non-small cell lung cancer. The company is also developing drugs for the treatment of chronic obstructive pulmonary disease (COPD) and spinal cord injuries.
In addition to its drug development programs, Geron also has a stem cell research division that focuses on the development of treatments for degenerative diseases such as Alzheimer's and Parkinson's disease.
Geron has partnerships with several major pharmaceutical companies, including Janssen Biotech and Merck, to develop and commercialize its drug candidates. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol GERN.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Geron's lead drug candidate is imetelstat, which is being developed as a treatment for myelofibrosis, a type of blood cancer, and for solid tumors such as non-small cell lung cancer. The company is also developing drugs for the treatment of chronic obstructive pulmonary disease (COPD) and spinal cord injuries.
In addition to its drug development programs, Geron also has a stem cell research division that focuses on the development of treatments for degenerative diseases such as Alzheimer's and Parkinson's disease.
Geron has partnerships with several major pharmaceutical companies, including Janssen Biotech and Merck, to develop and commercialize its drug candidates. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol GERN.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!